| 注册
首页|期刊导航|中国临床药理学杂志|艾司氯胺酮复合瑞马唑仑应用于前列腺癌根治术对麻醉效果的影响

艾司氯胺酮复合瑞马唑仑应用于前列腺癌根治术对麻醉效果的影响

邱靖 唐智豪 蔡振 周鹏飞

中国临床药理学杂志2025,Vol.41Issue(4):472-476,5.
中国临床药理学杂志2025,Vol.41Issue(4):472-476,5.DOI:10.13699/j.cnki.1001-6821.2025.04.005

艾司氯胺酮复合瑞马唑仑应用于前列腺癌根治术对麻醉效果的影响

Effect of esketamine combined with remimazolam on anesthetic effect in radical prostatectomy for prostate cancer

邱靖 1唐智豪 1蔡振 1周鹏飞2

作者信息

  • 1. 浙江大学医学院附属金华医院/金华市中心医院麻醉科,浙江金华 321000
  • 2. 浙江大学医学院附属金华医院/金华市中心医院泌尿科,浙江金华 321000
  • 折叠

摘要

Abstract

Objective To observe the anesthetic effect of esketamine injection combined with remimazolam injection in radical prostatectomy for prostate cancer.Methods The patients were divided into the control group and the treatment group according to cohort method.The control group was given anesthesia induction with remimazolam injection at 0.2 mg·kg-1combined with propofol injection at 1 mg·kg-1.The treatment group was given anesthesia induction with esketamine injection at 0.5 mg·kg-1 combined with remimazolam injection at 0.1 mg·kg-1.Both groups underwent maintenance of anesthesia with propofol injection at 4-8 mg·kg-1·h-1 combined with remifentanil injection at 5-10 μg·kg-1·h-1.The analgesic effect,sedative effect,hemodynamics[before anesthesia(T0),tracheal intubation(T1),30 min after the beginning of surgery(T2),2 h after surgery(T3)],stress(T0~T3)and safety were compared between the two groups.Results The control group and the treatment group were enrolled in 44 cases and 42 cases,respectively.At 3 h,6 h,12 h and 24 h after surgery,the Numerical Rating Scale(NRS)scores of the treatment groups were 2.71±0.46,2.52±0.43,2.24±0.32 and 2.25±0.29;the dosage of patient-controlled intravenous analgesia(PCIA)was(52.38±6.67)mL.At 3 h,6 h,12 h and 24 h after surgery,NRS scores of the control group were 3.49±0.52,3.27±0.44,2.73±0.41 and 2.54±0.39;the dosage of PCIA was(64.79±7.45)mL.For the treatment group,heart rate(HR)were(105.48±3.34),(102.67±3.45)and(100.29±1.93)beat·min-1 from T1,T2,T3;serum cortisol(Cor)levels at T1 and T2 were(257.68±29.18)and(303.75±31.52)nmoL·L-1;serum superoxide dismutase(SOD)levels at T2 and T3 were(425.85±50.45)and(422.96±50.21)U·L-1.For the control group,HR were(95.38±2.26),(91.52±2.68)and(87.15±1.40)beats·min-1 from T1,T2,T3;serum Cor levels at T1 and T2 were(307.36±32.11)and(322.38±33.45)nmoL·L-1;serum SOD levels at T2 and T3 were(401.23±46.21)and(388.24±45.87)U·L-1.The differences were statistically significant(all P<0.05).Adverse drug reactions in the treatment group mainly included emergence agitation,nausea and vomiting.Adverse drug reactions in the control group mainly included diplopia,emergence agitation,nausea and vomiting.The total incidence rates of adverse drug reactions in the treatment group and the control group were 13.64%(6 cases/44 cases)and 16.67%(7 cases/42 cases),without statistically significant difference(P>0.05).Conclusion Esketamine injection combined with remimazolam injection can achieve good anesthetic effect on patients undergoing radical prostatectomy for prostate cancer,which can effectively alleviate postoperative pain and physiological stress,and facilitate postoperative early functional recovery,with good safety.

关键词

艾司氯胺酮注射液/瑞马唑仑注射液/前列腺癌根治术/镇痛/机体应激/麻醉复苏/功能恢复

Key words

esketamine injection/remimazolam injection/radical prostatectomy for prostate cancer/analgesia/stress/anesthesia recovery/functional recovery

引用本文复制引用

邱靖,唐智豪,蔡振,周鹏飞..艾司氯胺酮复合瑞马唑仑应用于前列腺癌根治术对麻醉效果的影响[J].中国临床药理学杂志,2025,41(4):472-476,5.

中国临床药理学杂志

OA北大核心

1001-6821

访问量0
|
下载量0
段落导航相关论文